Healthy Life

Medical Science. How to Expedite Introduction into Practical Healthcare

04 Jun , 16:30–17:45
‘Healthy Life’ Programme
Panel session
Pavilion F, Healthy Life Area
Session sponsored by Sechenov University

Historically, Russian science has a strong systematic foundation and a unique potential focused on breakthrough discoveries, development of leading technologies, and implementation of innovative products that ensure preservation and improvement of people’s lives. Today, however, the volume of scientific results exceeds that of solutions introduced into practice: research and development do not always reflect the current needs of the public and are not always in demand by the healthcare system. Unfavourable factors for the growth of the Russian medical science include inter-departmental disconnectedness and low innovative activity of business. Thus, results of scientific achievements are poorly integrated into healthcare and a situation of lost opportunities for use of new drugs and technologies is created in society. Building a favourable environment for medical science is a strategic task of the national government policy growth. It starts with systematic analysis of practical healthcare needs, an expert evaluation of research and development, and goes all the way to building strategies for financing and introducing scientific achievements into the healthcare system. The year 2020 has given a special standing to international cooperation in development of medical science, setting the course toward sharing experience and looking for new growth paths, and that means restoring the status quo of Russian science among the leading global scientific countries.
● How well does the Strategy for the Development of Medical Science in the Russian Federation until 2025 correspond to the goals of strengthening the industry’s positions?
● Solution of which problems will promote the advancement of the level of fundamental and applicable scientific research and growth of the scientific human capital?
● How can innovative activity of Russian business be increased and the share of R&D in the national pharma industry enlarged?
● What state strategies should promote expedited introduction of scientific research results into practical healthcare?
● How can the process of integrating Russian medical science into the global science community be expedited?

Evelina Zakamskaya, Editor-in-Chief, Doctor Channel; Anchor, Russia 24

Petr Glybochko, Rector, I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation
Andrey Kaprin, Director, Federal State Budgetary Institution National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation
Vladimir Lazar, Chief Scientific and Operating Officer Worldwide Innovative Network Association - WIN Consortium (online)
Alla Samoylova, Head, Federal Service for Surveillance in Healthcare (Roszdravnadzor)
Tatyana Semenova, Deputy Minister of Health of the Russian Federation
Veronika Skvortsova, Head, Federal Medical-Biological Agency of the Russian Federation
Shahrokh Shariat, Chairman, Department of Urology of the Medical University of Vienna (online)

Front row participants
Dmitry Kudlay, General Director, Generium
Simon Matskeplishvili, Deputy Scientific Director, Lomonosov Moscow State University Clinic; Member of the Board, Russian Society of Cardiology
Vadim Merkulov, Deputy Director General for Drug Expertise, Scientific Centre for Expert Evaluation of Medicinal Products of the Ministry of Health of the Russian Federation